TLN2
Basic information
Region (hg38): 15:62390526-62844631
Links
Phenotypes
GenCC
Source:
- camptodactyly of fingers (Limited), mode of inheritance: AD
- Tourette syndrome (Limited), mode of inheritance: Unknown
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TLN2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 20 | 29 | ||||
missense | 157 | 166 | ||||
nonsense | 0 | |||||
start loss | 1 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 2 | 1 | 3 | |||
non coding | 1 | |||||
Total | 0 | 0 | 159 | 25 | 13 |
Variants in TLN2
This is a list of pathogenic ClinVar variants found in the TLN2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
15-62647341-C-T | not specified | Uncertain significance (Jul 25, 2023) | ||
15-62647363-C-T | not specified | Uncertain significance (Dec 06, 2024) | ||
15-62647369-A-G | Uncertain significance (Apr 01, 2019) | |||
15-62647404-C-G | not specified | Uncertain significance (Oct 26, 2022) | ||
15-62650084-C-T | not specified | Uncertain significance (Sep 24, 2024) | ||
15-62652047-C-T | not specified | Uncertain significance (Apr 12, 2023) | ||
15-62653165-T-C | not specified | Uncertain significance (May 05, 2023) | ||
15-62653217-A-C | not specified | Uncertain significance (Feb 11, 2022) | ||
15-62655978-A-C | not specified | Uncertain significance (Sep 04, 2024) | ||
15-62656046-A-T | not specified | Uncertain significance (Dec 28, 2022) | ||
15-62657763-T-C | Benign (Mar 29, 2018) | |||
15-62673877-A-G | not specified | Uncertain significance (Nov 22, 2021) | ||
15-62675229-T-C | not specified | Uncertain significance (Apr 27, 2024) | ||
15-62675232-G-A | not specified | Uncertain significance (Oct 24, 2024) | ||
15-62675235-G-C | not specified | Uncertain significance (Nov 13, 2024) | ||
15-62675268-G-A | not specified | Uncertain significance (May 08, 2023) | ||
15-62675274-C-T | not specified | Uncertain significance (May 03, 2023) | ||
15-62675276-C-T | Likely benign (Feb 01, 2023) | |||
15-62686654-G-A | not specified | Uncertain significance (Oct 08, 2024) | ||
15-62686667-G-C | Likely benign (Dec 31, 2019) | |||
15-62686671-C-T | not specified | Uncertain significance (Oct 14, 2021) | ||
15-62686765-G-T | not specified | Uncertain significance (May 14, 2024) | ||
15-62692848-G-A | Likely benign (Jun 11, 2018) | |||
15-62692878-A-C | not specified | Uncertain significance (Dec 07, 2023) | ||
15-62692880-C-G | not specified | Uncertain significance (Aug 04, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TLN2 | protein_coding | protein_coding | ENST00000561311 | 56 | 454106 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.992 | 0.00769 | 125692 | 0 | 56 | 125748 | 0.000223 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.41 | 1341 | 1.49e+3 | 0.897 | 0.0000907 | 16479 |
Missense in Polyphen | 250 | 352.57 | 0.70908 | 3916 | ||
Synonymous | -2.28 | 700 | 627 | 1.12 | 0.0000444 | 5141 |
Loss of Function | 8.41 | 26 | 129 | 0.201 | 0.00000651 | 1501 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000360 | 0.000360 |
Ashkenazi Jewish | 0.000397 | 0.000397 |
East Asian | 0.000221 | 0.000217 |
Finnish | 0.0000949 | 0.0000924 |
European (Non-Finnish) | 0.000212 | 0.000211 |
Middle Eastern | 0.000221 | 0.000217 |
South Asian | 0.000263 | 0.000261 |
Other | 0.000819 | 0.000815 |
dbNSFP
Source:
- Function
- FUNCTION: As a major component of focal adhesion plaques that links integrin to the actin cytoskeleton, may play an important role in cell adhesion. Recruits PIP5K1C to focal adhesion plaques and strongly activates its kinase activity (By similarity). {ECO:0000250}.;
- Pathway
- Platelet activation - Homo sapiens (human);Focal adhesion - Homo sapiens (human);HTLV-I infection - Homo sapiens (human);Rap1 signaling pathway - Homo sapiens (human);Focal Adhesion;Integrin
(Consensus)
Recessive Scores
- pRec
- 0.447
Intolerance Scores
- loftool
- 0.525
- rvis_EVS
- -3.47
- rvis_percentile_EVS
- 0.35
Haploinsufficiency Scores
- pHI
- 0.306
- hipred
- Y
- hipred_score
- 0.637
- ghis
- 0.553
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.701
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Tln2
- Phenotype
- behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; muscle phenotype; cellular phenotype;
Gene ontology
- Biological process
- cytoskeletal anchoring at plasma membrane;cell-cell junction assembly;cell adhesion
- Cellular component
- ruffle;cytoplasm;plasma membrane;focal adhesion;actin cytoskeleton;synapse
- Molecular function
- actin binding;structural molecule activity;structural constituent of cytoskeleton;protein binding;actin filament binding